Antria Overview

  • Founded
  • 2010
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • (Cancelled)

Antria General Information


Operator of a clinical research organization. The company focuses on the discovery and development of new products and treatments with stem cells derived from adult patients' own fat cells, known as autologous derived stem cells to help patients with various chronic and acute medical conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Primary Office
  • 841 Hospital Road
  • Suite 2400
  • Indiana, PA 15701
  • United States
+1 (724) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Antria Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 30-Jul-2015 Cancelled Startup
1. Angel (individual) 24-Jan-2013 00.000 00.000 Completed Startup
To view Antria’s complete valuation and funding history, request access »

Antria Executive Team (5)

Name Title Board Seat Contact Info
Leonard Maliver MD Chief Executive Officer & Board Member
Shah Rahimian MD President, Research & Development & Board Member
John Kriak Assisant Secretary, Assistant Treasurer and Chief Financial Officer
David Bizousky MD Medical Monitor & Board Member
Sharon Barto Vice President, Business Development & Board Member
To view Antria’s complete executive team members history, request access »

Antria Board Members (4)

Name Representing Role Since
David Bizousky MD Antria Medical Monitor & Board Member 000 0000
Leonard Maliver MD Antria Chief Executive Officer & Board Member 000 0000
Shah Rahimian MD Antria President, Research & Development & Board Member 000 0000
Sharon Barto Antria Vice President, Business Development & Board Member 000 0000
To view Antria’s complete board members history, request access »